UK Denies Pfizer’s Bid To Clear Path For Biosimilar Bevacizumab

Pfizer cannot get a UK Arrow declaration clearing it of infringement of pending bevacizumab patent applications through the biosimilar it plans to import from Belgium because Roche has already de-designated the UK parts of the applications.